DD283603A5 - Verfahren zur herstellung von substituierten hydroxylaminen - Google Patents

Verfahren zur herstellung von substituierten hydroxylaminen Download PDF

Info

Publication number
DD283603A5
DD283603A5 DD88322085A DD32208588A DD283603A5 DD 283603 A5 DD283603 A5 DD 283603A5 DD 88322085 A DD88322085 A DD 88322085A DD 32208588 A DD32208588 A DD 32208588A DD 283603 A5 DD283603 A5 DD 283603A5
Authority
DD
German Democratic Republic
Prior art keywords
aryl
alkyl
substituted
trifluoromethyl
alkylsulfonyl
Prior art date
Application number
DD88322085A
Other languages
German (de)
English (en)
Inventor
Walter Huebsch
Rolf Angerbauer
Peter Fey
Hilmar Bischoff
Dieter Petzinna
Delf Schmidt
Original Assignee
������@������������k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ������@������������k�� filed Critical ������@������������k��
Publication of DD283603A5 publication Critical patent/DD283603A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/335Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C239/00Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
    • C07C239/08Hydroxylamino compounds or their ethers or esters
    • C07C239/18Hydroxylamino compounds or their ethers or esters having nitrogen atoms of hydroxylamino groups further bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Indole Compounds (AREA)
  • Pyridine Compounds (AREA)
DD88322085A 1987-11-25 1988-11-23 Verfahren zur herstellung von substituierten hydroxylaminen DD283603A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873739882 DE3739882A1 (de) 1987-11-25 1987-11-25 Substituierte hydroxylamine

Publications (1)

Publication Number Publication Date
DD283603A5 true DD283603A5 (de) 1990-10-17

Family

ID=6341199

Family Applications (1)

Application Number Title Priority Date Filing Date
DD88322085A DD283603A5 (de) 1987-11-25 1988-11-23 Verfahren zur herstellung von substituierten hydroxylaminen

Country Status (16)

Country Link
US (2) US4968681A (da)
EP (1) EP0317845A3 (da)
JP (1) JPH01165554A (da)
KR (1) KR890008092A (da)
CN (1) CN1033991A (da)
AU (1) AU2590288A (da)
DD (1) DD283603A5 (da)
DE (1) DE3739882A1 (da)
DK (1) DK656588A (da)
FI (1) FI885427L (da)
HU (1) HU203722B (da)
IL (1) IL88446A0 (da)
NO (1) NO885117L (da)
NZ (1) NZ227031A (da)
PT (1) PT89056A (da)
ZA (1) ZA888789B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5354772A (en) * 1982-11-22 1994-10-11 Sandoz Pharm. Corp. Indole analogs of mevalonolactone and derivatives thereof
EP0679157B1 (en) 1993-01-15 1997-11-19 G.D. Searle & Co. Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents
US6492413B2 (en) 1993-01-15 2002-12-10 G.D. Searle & Co. 3.4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
DE19513716A1 (de) * 1995-02-01 1996-08-08 Bayer Ag Substituierte 2-Phenylindol-Derivate
GB9411088D0 (en) * 1994-06-03 1994-07-27 Hoffmann La Roche Hydroxylamine derivatives
WO1998025896A1 (en) * 1996-12-10 1998-06-18 G.D. Searle & Co. Substituted pyrrolyl compounds for the treatment of inflammation
US6355812B1 (en) 1999-06-11 2002-03-12 Orth-Mcneil Pharmaceutical, Inc. Methods for the synthesis of dioxoalkanoic acid compounds
CA2445712A1 (en) * 2001-05-31 2002-12-05 Cellegy Pharmaceuticals, Inc. Store operated calcium influx inhibitors and methods of use
AR034772A1 (es) 2001-07-13 2004-03-17 Astrazeneca Uk Ltd Preparacion de los compuestos de aminopirimidina
MXPA06006396A (es) * 2004-01-20 2006-08-23 Warner Lambert Co Inhibidores de hmg-coa reductasa basados en imidazol.
GB0428328D0 (en) * 2004-12-24 2005-02-02 Astrazeneca Uk Ltd Chemical process
CN112159333A (zh) * 2020-10-15 2021-01-01 济宁康德瑞化工科技有限公司 一种双羟丙基羟胺的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3897465A (en) * 1971-03-29 1975-07-29 Airco Inc Ethyl beta-(N-methylfurfurylamino) propionate
US3760086A (en) * 1971-03-29 1973-09-18 Airco Inc Tranquilizer
BE848465A (fr) * 1976-11-18 1977-03-16 Stereo-isomeres de 1-(1'-benzyl-2' pyrryl)-2-disec.butylaminoethanols a activite analgesique et preparations pharmaceutiques qui les contiennent
GR69216B (da) * 1979-06-15 1982-05-07 Merck & Co Inc
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
WO1984002131A1 (fr) * 1982-11-22 1984-06-07 Sandoz Ag Produits analogues de mevalolactone et leurs derives, leurs procedes de production, compositions pharmaceutiques les contenant ainsi que leur utilisation en tant que produits pharmaceutiques
US4595693A (en) * 1984-06-04 1986-06-17 Merck & Co., Inc. Method of use of 2,5-diaryl tetrahydrofurans and analogs thereof as PAF-antagonists
US4613610A (en) * 1984-06-22 1986-09-23 Sandoz Pharmaceuticals Corp. Cholesterol biosynthesis inhibiting pyrazole analogs of mevalonolactone and its derivatives

Also Published As

Publication number Publication date
KR890008092A (ko) 1989-07-08
NZ227031A (en) 1990-09-26
IL88446A0 (en) 1989-06-30
JPH01165554A (ja) 1989-06-29
NO885117L (no) 1989-05-26
HUT52068A (en) 1990-06-28
PT89056A (pt) 1989-11-30
US4968681A (en) 1990-11-06
DK656588D0 (da) 1988-11-24
EP0317845A2 (de) 1989-05-31
FI885427A7 (fi) 1989-05-26
NO885117D0 (no) 1988-11-16
DK656588A (da) 1989-05-26
US5032590A (en) 1991-07-16
ZA888789B (en) 1989-08-30
AU2590288A (en) 1989-06-01
EP0317845A3 (de) 1989-08-30
FI885427L (fi) 1989-05-26
FI885427A0 (fi) 1988-11-23
HU203722B (en) 1991-09-30
CN1033991A (zh) 1989-07-19
DE3739882A1 (de) 1989-06-08

Similar Documents

Publication Publication Date Title
EP0373423B1 (de) Substituierte 2-Pyridone und Pyrid-2-thione, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE69431042T2 (de) Pyrazol oder isoxazol substituierte alkylamide als acat inhibitoren
EP1123925A1 (de) Verfahren zur Herstellung von substituierten Pyridinen
DE19741051A1 (de) Hetero-Tetrahydrochinoline
EP0287890A1 (de) Substituierte Pyrrole
EP0183159A2 (de) 1-Heteroaryl-4-aryl-pyrazolin-5-one zur Verwendung als Arzneimittel
DE69225123T2 (de) Thiazolidinederivate, die eine Quinone-Gruppe enthalten, ihre Herstellung und therapeutische Anwendung
EP0317845A2 (de) Substituierte Hydroxylamine
EP0174910B1 (de) Verfahren zur Herstellung von 4-Phenyl-pyrrol-derivaten
EP0220573B1 (de) Heterocyclische Verbindungen
EP0414076B1 (de) Cyclisch substituierte (Chinolin-2-yl-methoxy)phenyl-essigsäure-Derivate
DE3881817T2 (de) 3,5-Dihydroxy-6,8-nonadiensäuren und -derivate als hypocholesterolemische Mittel.
EP0116360B1 (de) 1-Phenyl-2-aminocarbonylindol-Verbindungen sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3817808A1 (de) Verfahren zur herstellung von 2-substituierten pyrrolen
EP0380712B1 (de) Verfahren zur Herstellung von 2,6-Dichlordiphenylaminessigsäurederivaten
EP0330057A2 (de) Substituierte Pyrimidine
DE3911064A1 (de) Substituierte 1,8-naphthyridine
DE69017511T2 (de) Butenoinsäure-Derivate.
EP0339342A1 (de) N-Substituierte N-Amino-pyrrole
CH653028A5 (de) Benzthiophenallylamin-verbindungen und verfahren zu ihrer herstellung.
EP0334014A2 (de) Substituierte Imidazolinone und Imidazolinthione
EP0334147A1 (de) Disubstituierte Pyrrole
DE3909378A1 (de) Substituierte biphenyle
EP0160173A1 (de) Benzothiazolderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltendes Arzneimittel
DE3929507A1 (de) Substituierte amino-pyridine

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee